Brief: LTR Pharma Seeks Trading Halt
04/06/2024 24:16
June 4 (Reuters) - LTR Pharma Ltd LTP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON INITIAL
CLINICAL
TRIAL RESULTS OF ITS PIVOTAL STUDY OF SPONTAN NASAL SPRAY
Further company coverage: LTP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ltr Pharma
See all newsAustralia's LTR Pharma surges as its drug begins US prescription fulfillment
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray